What question did this study set out to answer?

Examine the role of fibroblast growth factor-2 (FGF2) in protecting the heart from damage during ischemia-reperfusion.

December 2, 2003Circulation

Cardiac-Specific Overexpression of Fibroblast Growth Factor-2 Protects Against Myocardial Dysfunction and Infarction in a Murine Model of Low-Flow Ischemia

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates FGF2's cardioprotective effects against ischemic injury in murine models, suggesting significant benefits.

Examine the role of fibroblast growth factor-2 (FGF2) in protecting the heart from damage during ischemia-reperfusion.
Compared FGF2-deficient (knockout) mice and cardiac-specific overexpressing mice with wild-type mice.
Utilized an ex vivo heart model subjected to 60 minutes of low-flow ischemia followed by 120 minutes of reperfusion.
Assessed contractile function and myocardial infarct size post-reperfusion.
Fgf2 knockout hearts recovered to 27% of baseline post-ischemia compared to 63% in wild-type hearts (P<0.05).
FGF2 Tg hearts demonstrated 88% recovery of function post-ischemia (P<0.05).
Infarct size was reduced in FGF2 Tg hearts (13%) compared to wild-type (30%, P<0.05).

House et al. (2003) studied this question.

View Full Paper

Ask AI

Bookmark